Sweden stands up for open access – cancels agreement with Elsevier LUBcat LIBRIS

Olli-P. Kallioniemi. National Human Genome Research Institute, National. Institutes of Health, Bethesda, USA. CV. EDUCATION: 1985 M.D., University of

University of Helsinki, Department of Molecular Medicine. Veileder. Nilsson, Mats. Uppsala universitet, Medicinska och farmaceutiska Olli Kallioniemi is an inventor and co-inventor of 21 issued patents, with a focus on diagnostic technology development, such as FISH, Comparative Genomic Hybridization, tissue microarrays, cell microarrays and bioinformatic methods. Many of these patents have been licensed for product development and applied to launch spinoff companies. Olli Kallioniemi is an author of 310 publications, a member of the editorial board of six journals and invited lecturer in over 90 meetings during the past 4 years.

Kallioniemi olli

Kallioniemi; Holger Moch; Christos H. Jan 1, 2001 to a region of amplification in chromosome 20. Inventors: Gray, Joe W; Collins, Colin; Pinkel, Daniel; Kallioniemi, Olli-Pekka; Tanner, Minna M FIMM - Institiute for Molecular Medicine Finland www.fimm.fi. October 9, 2013. Suomalainen genomitieto ja yksilöllistetty terveydenhuolto.

SciLifeLab, ett nationellt center för molekylära biovetenskaper, får med Olli Kallioniemi sin andra direktör sedan starten 2010. Olli Kallioniemi's 169 research works with 442 citations and 4,500 reads, including: Supplementary Material 4 Professor of Molecular Precision Medicine. Professor Olli Kallioniemi (born 1960) is a founder and board member of Sartar Therapeutics.

Olli Kallioniemi's 169 research works with 442 citations and 4,500 reads, including: Supplementary Material 4

Olli Kallioniemi sai tämän vuoden Äyräpää-palkinnon. on myöntänyt vuoden 2019 Äyräpää-palkinnon professori Olli Kallioniemelle. 14. marraskuu 2008 Professori Olli Kallioniemi johtaa biotekniikan huippututkimusta Suomen molekyylilääketieteen instituutissa FIMM:ssä.

Olli Kallioniemi, professor, director at the Science for Life Laboratory (SciLifeLab) Hanna Axelsson, project manager Tom Erkers, assistant professor Emilie Flaberg, postdoc Greta Gudoityte, lab engineer Tojo James, bioinformatician Kasper Karlsson, assistant professor

Kallioniemi i covid-19 och möjligheter att individanpassa behandlingar, säger Olli Kallioniemi, direktör för SciLifeLab, i ett pressmeddelande. Knut och KALLIONIEMI, Olli-Pekka.

Laji vei Ollin täysin mennessään. Nyt hän ohjaa nuoria ja aikuisia joka päivä useamman tunnin.
Parkeringsregler skyltar stockholm

A METHOD FOR FINDING PUTATIVE CAUSES OF GENE EXPRESSION VARIATION Reija Autio 1, Sampsa Hautaniemi , Markus Ringnér2, Päivikki Kauraniemi3 ,Henrik Edgren4,5, Olli Yli-Harja 1, Jaakko Astola , Anne Kallioniemi3, Olli-Pekka Kallioniemi4 1Institute of Signal Processing, Tampere University of Technology, P.O. Box 553, Tampere FIN- 33101, Finland, 2Department of Theoretical Physics, Lund Olli-Pekka Kallioniemi Label from public data source Wikidata Sources found : Tissue microarray technology for genome-scale transitional cancer research, 1999: label (Olli P. Kallioniemi) narration (section head of a group in the National Human Genome Research Institute intramural program) data-flow analysis. rule-based. Filter by Venue Espen Enerly 1 , Israel Steinfeld, Kristine Kleivi, Suvi-Katri Leivonen, Miriam R Aure, Hege G Russnes, Jo Anders Rønneberg, Hilde Johnsen, Roy Navon, Einar Rødland, Rami Mäkelä, Bjørn Naume, Merja Perälä, Olli Kallioniemi, Vessela N Kristensen, Zohar Yakhini, Anne-Lise Børresen-Dale KALLIONIEMI OLLI SAUTER GUIDO LEIGHTON STEPHEN B. KONONEN JUHA POHIDA THOMAS J. KARAREKA JOHN WILLIAM SALEM GHADI HAMDI .

Larne, Olivia; Östling, Päivi; Haflidadottir, Benedikta; Hagman, Zandra; Aakula, Anna; Kohonen, Pekka; Kallioniemi, Olli; Edsjö, Anders; Bjartell, Anders; Lilja, Olli Kallioniemi svarar på frågor om dagens och framtidens cancerforskning.
Mckinley

föga samlad
vad betyder voucher på svenska
25 moms på 1000 kr
parkering elbil regler
sarstedt abstrich für pcr
tor pelare
aktier og obligationer kurser

A STRATEGY FOR IDENTIFYING PUTATIVE CAUSES OF GENE EXPRESSION VARIATION IN HUMAN CANCER Sampsa Hautaniemi1, Markus Ringnér2, Päivikki Kauraniemi3, Anne Kallioniemi3, Henrik Edgren4, Olli Yli-Harja 1, Jaakko Astola1, Olli-P. Kallioniemi2 1Institute of Signal Processing, Tampere University of Technology, Finland, 2Cancer Genetics Branch, National Human Genome Research …

Olli Kallioniemi's 3 research works with 20 citations and 257 reads, including: Publisher Correction: Building an international consortium for tracking coronavirus health status 2020-12-24: Identification of structural features in chemicals associated with cancer drug response : a systematic data-driven analysis View the profiles of people named Olli Kallioniemi. Join Facebook to connect with Olli Kallioniemi and others you may know. Facebook gives people the On November 28, the Swedish Minister for Higher Education and Research, Helene Hellmark Knutsson, presented the research bill for 2017-2020 at SciLifeLab in Solna. “The bill gives SciLifeLab the same level of funding as during the last period, providing continuity and long-term perspective for Olli-Pekka Kallioniemi (s.20. marraskuuta 1960 Karkku) on molekulaarisen täsmälääketieteen professori Karoliinisessä instituutissa ja Science for Life Laboratoryn (SciLifeLab) johtaja. SciLifeLab on neljän ruotsalaisen yliopiston – Karoliininen instituutti, Kuninkaallinen teknillinen korkeakoulu, Tukholman yliopisto ja Uppsalan yliopisto – yhdessä perustama, noin 1 200 työntekijän Olli Kallioniemi has filed for patents to protect the following inventions.

2015. Studiens namn: Personalized Systems Medicine Strategy for Acute Myeloid Leukemia. Ansvarig forskare: Olli Kallioniemi, Science for Life Laboratory,

Hallå där Olli Kallioniemi, professor i molekylär precisionsmedicin och direktör för SciLifeLab. Vilka anser du vara de största utmaningarna för dagens cancerforskning?

In addition, FIMM and SciLifeLab intend to start a close collaboration in infrastructure services as well as in joint research programs to enable new possibilities for both institutes, the participating Universities and the two countries. The board of SciLifeLab has appointed Professor Olli Kallioniemi as new Director from July 1, 2015. Professor Kallioniemi will be in full service from September 2015. He will present his research at SciLifeLab Day on April 29 in Aula Medica at Karolinska Institutet, Solna. ‘Olli Kallioniemi has demonstrated leadership, scientific excellence and vision, both as a researcher and as an advocate of bringing the benefits of molecular medicine to patients.’ Olli Kallioniemi succeeds Mathias Uhlén, who has served as Director since the start of SciLifeLab in Stockholm in 2010 and later for the joint national center with Uppsala starting in 2013.